Mucoadhesive polymers for buccal drug delivery

Drug Development and Industrial Pharmacy

Volumn 40, Issue 5, 2014, Pages 591-598

  Laffleur, Flavia ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Buccal drug delivery; Buccal mucosa; Mucoadhesion; Mucoadhesive polymers; PAT generation

Indexed keywords

ADHESIVE AGENT; AMINOPEPTIDASE; BUSERELIN; CALCITONIN; CAPTOPRIL; CARBOMER; CARBOXYMETHYLCELLULOSE; CARBOXYPEPTIDASE; ESTERASE; GLUTAMIC ACID; GONADORELIN; HYALURONIC ACID; HYDROXYL GROUP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LYSINE; OCTREOTIDE; OLIGOSACCHARIDE; OXYTOCIN; PEPTIDE; POLOXAMER; POLYMER; PROTEIN; PROTIRELIN; XANTHAN; DRUG DOSAGE FORM;

ANATOMY; CHEEK MUCOSA; CHEMICAL STRUCTURE; COVALENT BOND; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG RELEASE; ELASTICITY; FIRST PASS EFFECT; HYDROGEN BOND; MOLECULAR WEIGHT; MOUTH CAVITY; MOUTH MUCOSA; MUCOADHESION; OINTMENT; PATIENT COMPLIANCE; PHYSICAL CHEMISTRY; REVIEW; SURFACE TENSION; YOUNG MODULUS; ANATOMY AND HISTOLOGY; ANIMAL; BIOAVAILABILITY; BUCCAL DRUG ADMINISTRATION; CHEMISTRY; DRUG DOSAGE FORM; GASTROINTESTINAL ABSORPTION; HUMAN; METABOLISM;

ADHESIVES; ADMINISTRATION, BUCCAL; ANIMALS; BIOLOGICAL AVAILABILITY; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; HUMANS; MOUTH MUCOSA; ORAL MUCOSAL ABSORPTION; PEPTIDES; POLYMERS; PROTEINS;

EID: 84898615127     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.892959     Document Type: Review

References (71)

1. Laffleur F, Shahnaz G, Islambulchilar Z, Bernkop-Schnurch A. Design and in vitro evaluation of a novel polymeric excipient for buccal applications. Future Med Chem 2013;5:511-22
2. de Vries ME, Bodde HE, Verhoef JC, Junginger HE. Developments in buccal drug delivery. Crit Rev Ther Drug Carrier Syst 1991;8: 271-303
3. Peppas NA, Thomas JB, McGinty J. Molecular aspects of mucoadhesive carrier development for drug delivery and improved absorption. J Biomater Sci Polym Ed 2009;20:1-20
4. Peppas NA, Sahlin JJ. Hydrogels as mucoadhesive and bioadhesive materials: A review. Biomaterials 1996;17:1553-61
5. Hombach J, Bernkop-Schnurch A. Mucoadhesive drug delivery systems. Handb Exp Pharmacol 2010;197:251-66
6. Albrecht K, Bernkop-Schnurch A. Thiomers: Forms, functions and applications to nanomedicine. Nanomedicine (Lond) 2007;2:41-50
7. Laffleur F, Bernkop-Schnurch A. Thiomers: Promising platform for macromolecular drug delivery. Future Med Chem 2012;4:2205-16
8. Gandhi RB, Robinson Jr. Oral cavity as a site for bioadhesive drugdelivery. Adv Drug Deliver Rev 1994;13:43-74
9. Harris D, Robinson Jr. Drug delivery via the mucous-membranes of the oral cavity. J Pharm Sci-Us 1992;81:1-10
10. Collins LM, Dawes C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res 1987;66:1300-2
11. Galey WR, Lonsdale HK, Nacht S. The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water. J Invest Dermatol 1976;67:713-17
12. Sloan P, Picardo M, Schor SL. The structure and function of oral mucosa. Dent Update 1991;18:208-12
13. Shakya P, Madhav NV, Shakya AK, Singh K. Palatal mucosa as a route for systemic drug delivery: A review. J Control Release 2011; 151:2-9
14. Laffleur F, Bernkop-Schnurch A. Strategies for improving mucosal drug delivery. Nanomedicine (Lond) 2013;8:2061-75
15. Cone RA. Barrier properties of mucus. Adv Drug Deliver Rev 2009; 61:75-85
16. Hao JS, Heng PWS. Buccal delivery systems. Drug Dev Ind Pharm 2003;29:821-32
17. Shojaei AH, Berner B, Xiaoling L. Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport. Pharm Res 1998;15:1182-8
18. Birudaraj R, Berner B, Shen S, Li X. Buccal permeation of buspirone: Mechanistic studies on transport pathways. J Pharm Sci-Us 2005;94:70-8
19. Senel S, Kremer M, Nagy K, Squier C. Delivery of bioactive peptides and proteins across oral (buccal) mucosa. Curr Pharm Biotechnol 2001;2:175-86
20. Utoguchi N, Watanabe Y, Suzuki T, et al. Carrier-mediated transport of monocarboxylic acids in primary cultured epithelial cells from rabbit oral mucosa. Pharm Res 1997;14:320-4
21. Junginger HE, Hoogstraate JA, Verhoef JC. Recent advances in buccal drug delivery and absorption-in vitro and in vivo studies. J Control Release 1999;62:149-59
22. Carvalho FC, Bruschi ML, Evangelista RC, Gremiao MPD. Mucoadhesive drug delivery systems. Braz J Pharm Sci 2010;46: 1-17
23. Shaikh R, Raj Singh TR, Garland MJ, et al. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci 2011;3:89-100
24. Khutoryanskiy VV. Advances in mucoadhesion and mucoadhesive polymers. Macromol Biosci 2011;11:748-64
25. Wang XQ, Iqbal J, Rahmat D, Bernkop-Schnurch A. Preactivated thiomers: Permeation enhancing properties. Int J Pharm 2012;438: 217-24
26. Hintzen F, Laffleur F, Sakloetsakun D, et al. In situ gelling properties of anionic thiomers. Drug Dev Ind Pharm 2012;38: 1479-85
27. Sakloetsakun D, Perera G, Hombach J, et al. The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: A case study with chitosan-4-Thiobutylamidine conjugate. AAPS PharmSciTech 2010;11:1185-92
28. Mazzarino L, Travelet C, Ortega-Murillo S, et al. Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J Colloid Interf Sci 2012;370:58-66
29. de Araujo Pereira RR, Bruschi ML. Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm 2012;38:643-52
30. Millotti G, Samberger C, Frohlich E, et al. Chitosan-4-mercaptobenzoic acid: Synthesis and characterization of a novel thiolated chitosan. J Mater Chem 2010;20:2432-40
31. Barthelmes J, Dunnhaupt S, Unterhofer S, et al. Thiolated particles as effective intravesical drug delivery systems for treatment of bladder-related diseases. Nanomedicine (Lond) 2013;8:65-75
32. Mueller C, Verroken A, Iqbal J, Bernkop-Schnuerch A. Thiolated chitosans: In vitro comparison of mucoadhesive properties. J Appl Polym Sci 2012;124:5046-55
33. Pather SI, Rathbone MJ, Senel S. Current status and the future of buccal drug delivery systems. Expert Opin Drug Deliv 2008;5: 531-42
34. Shinkar DM, Dhake AS, Setty CM. Drug delivery from the oral cavity: A focus on mucoadhesive buccal drug delivery systems. PDA J Pharm Sci Technol 2012;66:466-500
35. Lestari MLAD, Nicolazzo JA, Finnin BC. A novel flow through diffusion cell for assessing drug transport across the buccal mucosa in vitro. J Pharm Sci-Us 2009;98:4577-88
36. McElnay JC, Al-Furaih TA, Hughes CM, et al. Buccal absorption of enalapril and lisinopril. Eur J Clin Pharmacol 1998;54:609-14
37. Manning AS, Evered DF. The absorption of sugars from the human buccal cavity. Clin Sci Mol Med 1976;51:127-32
38. Rathbone MJ, Drummond BK, Tucker IG. The oral cavity as a site for systemic drug-delivery. Adv Drug Deliver Rev 1994;13:1-22
39. Giunchedi P, Juliano C, Gavini E, et al. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drugloaded chitosan microspheres. Eur J Pharm Biopharm 2002;53: 233-9
40. Tayel SA, Soliman II, Louis D. Formulation of ketotifen fumarate fast-melt granulation sublingual tablet. AAPS PharmSciTech 2010; 11:679-85
41. Langoth N, Kahlbacher H, Schöffmann G, et al. Thiolated chitosans: Design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system. Pharm Res 2006;23:573-9
42. Adhikari SNR, Nayak BS, Nayak AK, Mohanty B. Formulation and evaluation of buccal patches for delivery of atenolol. AAPS PharmSciTech 2010;11:1038-44
43. Palem CR, Gannu R, Doodipala N, et al. Transmucosal delivery of domperidone from bilayered buccal patches: In vitro, ex vivo and in vivo characterization. Arch Pharm Res 2011;34: 1701-10
44. Semalty M, Semalty A, Kumar G. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian J Pharm Sci 2008; 70:43-8
45. Boddupalli BM, Mohammed ZN, Nath RA, Banji D. Mucoadhesive drug delivery system: An overview. J Adv Pharm Technol Res 2010; 1:381-7
46. Semalty A, Semalty M, Nautiyal U. Formulation and evaluation of mucoadhesive buccal films of enalapril maleate. Indian J Pharm Sci 2010;72:571-5
47. Nappinnai M, Chandanbala R, Balaijirajan R. Formulation and evaluation of nitrendipine buccal films. Indian J Pharm Sci 2008;70: 631-5
48. Padula C, Pozzetti L, Traversone V, et al. In vitro evaluation of mucoadhesive films for gingival administration of lidocaine. AAPS PharmSciTech 2013;14:1279-83
49. Kumria R, Gupta V, Bansal S, et al. Oral buccoadhesive films of ondansetron: Development and evaluation. Int J Pharm Investig 2013;3:112-18
50. Muzib YI, Kumari KS. Mucoadhesive buccal films of glibenclamide: Development and evaluation. Int J Pharm Investig 2011;1: 42-7
51. Repka MA, McGinity JW. Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. J Control Release 2001;70:341-51
52. Ishida M, Nambu N, Nagai T. Ointment-Type oral mucosal dosage form of Carbopol containing prednisolone for treatment of aphtha. Chem Pharm Bull (Tokyo) 1983;31:1010-14
53. Miller SC, Donovan MD. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int J Pharm 1982;12: 147-52
54. Wong CF, Yuen KH, Peh KK. Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm 1999;178: 11-22
55. Kumar S, Haglund BO, Himmelstein KJ. In situ-forming gels for ophthalmic drug-delivery. J Ocul Pharmacol 1994;10:47-56
56. Gurny R, Ryser JE, Tabatabay C, et al. Precorneal residence time in humans of sodium hyaluronate as measured by gamma-scintigraphy. Graef Arch Clin Exp 1990;228:510-12
57. Meseguer G, Gurny R, Buri P, et al. Gamma-scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine. Int J Pharm 1993;95:229-34
58. Martin L, Wilson CG, Koosha F, Uchegbu IF. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm 2003;55:35-45
59. Jones DS, Woolfson AD, Brown AF, et al. Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Release 2000;67:357-68
60. Vinholis AH, Figueiredo LC, Marcantonio Junior E, et al. Subgingival utilization of a 1% chlorhexidine collagen gel for the treatment of periodontal pockets. A clinical and microbiological study. Braz Dent J 2001;12:209-13
61. Ikinci G, Senel S, Akincibay H, et al. Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. Int J Pharm 2002; 235:121-7
62. Hoogstraate AJ, Verhoef JC, Tuk B, et al. In-vivo buccal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs. J Pharm Sci-Us 1996; 85:457-60
63. Alur HH, Beal JD, Pather SI, et al. Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J Pharm Sci-Us 1999;88: 1313-19
64. Iscan YY, Capan Y, Senel S, et al. Formulation and in vitro in vivo evaluation of buccal bioadhesive captopril tablets. Stp Pharma Sci 1998;8:357-63
65. Nakane S, Kakumoto M, Yukimatsu K, Chien YW. Oramucosal delivery of LHRH: Pharmacokinetic studies of controlled and enhanced transmucosal permeation. Pharm Dev Technol 1996;1: 251-9
66. Merkle HP, Wolany G. Buccal delivery for peptide drugs. J Control Release 1992;21:155-64
67. Metia PK, Bandyopadhyay AK. In vitro and in vivo evaluation of a novel mucoadhesive buccal oxytocin tablet prepared with Dillenia indica fruit mucilage. Pharmazie 2008; 63:270-4
68. Li C, Bhatt PP, Johnston TP. Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch. Pharm Dev Technol 1997;2:265-74
69. Dillon TF, Douglas RG, Duvigneaud V, Barber ML. Transbuccal administration of pitocin for induction and stimulation of labor. Obstet Gynecol 1960;15:587-92
70. Anders R, Merkle HP, Schurr W, Ziegler R. Buccal absorption of protirelin-An effective way to stimulate thyrotropin and prolactin. J Pharm Sci-Us 1983;72:1481-3
71. Li C, Koch RL, Raul VA, et al. Absorption of thyrotropin-releasing hormone in rats using a mucoadhesive buccal patch. Drug Dev Ind Pharm 1997;23:239-46